Annovis Bio Inc (NYSE: ANVS) kicked off on Monday, up 7.67% from the previous trading day, before settling in for the closing price of $3.65. Over the past 52 weeks, ANVS has traded in a range of $1.11-$5.60.
It was noted that within the last five years, the titan of the Healthcare sector saw sales slided by -73.95%. While this was happening, its average annual earnings per share was recorded 43.52%. With a float of $22.41 million, this company’s outstanding shares have now reached $26.50 million.
Annovis Bio Inc (ANVS) Insider Updates
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of Annovis Bio Inc is 15.45%, while institutional ownership is 11.41%. The most recent insider transaction that took place on Dec 08 ’25, was worth 193,794. In this transaction Director of this company bought 45,000 shares at a rate of $4.31, taking the stock ownership to the 2,574,739 shares. Before that another transaction happened on Nov 24 ’25, when Company’s Director bought 39,200 for $4.08, making the entire transaction worth $159,886. This insider now owns 2,519,739 shares in total.
Annovis Bio Inc (ANVS) Performance Highlights and Predictions
According to the Wall Street analysts, stocks earnings will be around 43.52% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 18.51% during the next five years compared to -73.95% drop over the previous five years of trading.
Annovis Bio Inc (NYSE: ANVS) Trading Performance Indicators
Take a look at Annovis Bio Inc’s (ANVS) current performance indicators. Last quarter, stock had a quick ratio of 4.60.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.48, a number that is poised to hit -0.31 in the next quarter and is forecasted to reach -1.30 in one year’s time.
Technical Analysis of Annovis Bio Inc (ANVS)
The latest stats from [Annovis Bio Inc, ANVS] show that its last 5-days average volume of 0.63 million was inferior to 0.8 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 22.23%.
During the past 100 days, Annovis Bio Inc’s (ANVS) raw stochastic average was set at 60.05%, which indicates a significant increase from 34.56% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.38 in the past 14 days, which was higher than the 0.25 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $3.08, while its 200-day Moving Average is $2.41. Now, the first resistance to watch is $4.11. This is followed by the second major resistance level at $4.30. The third major resistance level sits at $4.55. If the price goes on to break the first support level at $3.67, it is likely to go to the next support level at $3.42. Assuming the price breaks the second support level, the third support level stands at $3.23.
Annovis Bio Inc (NYSE: ANVS) Key Stats
The company with the Market Capitalisation of 104.16 million has total of 26,503K Shares Outstanding. Its annual sales at the moment are 0 K in contrast with the sum of -24,590 K annual income. Company’s last quarter sales were recorded 0 K and last quarter income was -7,260 K.
